F.I.R.S.T.™ - a platform for effective drug discovery




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: F.I.R.S.T.™ - a platform for effective drug discovery
Released on: June 25, 2015. © PTV
Visitors: You are watching a 1 minute preview.
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    The strategic value of BioInvent consists of the patented technology platforms F I R S T™ and n-CoDeR®, as well as considerable expertise in pre-clinical and clinical development and the production of antibody-based drugs.
  • Summary
  • Transcript
  • Participants
  • Company
The strategic value of BioInvent consists of the patented technology platforms F I R S T™ and n-CoDeR®, as well as considerable expertise in pre-clinical and clinical development and the production of antibody-based drugs. This accumulated competence and know-how serve as the basis of revenue generating contract research and in-house strategic drug development. Michael Oredsson, CEO, BioInvent
Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.
The strategic value of BioInvent consists of the patented technology platforms F.I.R.S.T.™ and n-CoDeR®, as well as considerable expertise in pre-clinical and clinical development and the production of antibody-based drugs. This accumulated competence and know-how serve as the basis of revenue generating contract research and in-house strategic drug development. Michael Oredsson, CEO, BioInvent
BioInvent
BioInvent is a research-based pharmaceutical company developing innovative antibody drugs to target diseases with unmet clinical need. The company's pipeline currently includes product candidates for the treatment of cancer, thrombosis, atherosclerosis, and inflammatory diseases.